<code id='44463A39A5'></code><style id='44463A39A5'></style>
    • <acronym id='44463A39A5'></acronym>
      <center id='44463A39A5'><center id='44463A39A5'><tfoot id='44463A39A5'></tfoot></center><abbr id='44463A39A5'><dir id='44463A39A5'><tfoot id='44463A39A5'></tfoot><noframes id='44463A39A5'>

    • <optgroup id='44463A39A5'><strike id='44463A39A5'><sup id='44463A39A5'></sup></strike><code id='44463A39A5'></code></optgroup>
        1. <b id='44463A39A5'><label id='44463A39A5'><select id='44463A39A5'><dt id='44463A39A5'><span id='44463A39A5'></span></dt></select></label></b><u id='44463A39A5'></u>
          <i id='44463A39A5'><strike id='44463A39A5'><tt id='44463A39A5'><pre id='44463A39A5'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:124
          dose of methadone
          A dose of methadone Kevin D. Liles/AP

          The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

          To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges. 

          advertisement

          The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more
          Readout LOUD Podcast: Lilly's obesity drug, the power of radiation
          Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

          What’saradiopharmaceutical?WhatdoesitmeantobeZepbound?Andwho’stoblameforabiotechblow-up?Wecoverallth

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Study suggests Covid rebound is far more common with Paxlovid than without

          AdobeAsmallandpreliminarystudypublishedMondayseemstoindicatethatpatientsreceivingthedrugPaxlovidaref